Salivary Antibody Responses to Two COVID-19 Vaccines following Different Vaccination Regimens

Background: To date, little is known about the salivary mucosal immune response following different COVID-19 vaccine types or after a booster (3rd) dose of the BNT162b2 (BNT) vaccine. Methods: A total of 301 saliva samples were collected from vaccinated individuals and arranged into two cohorts: coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkharaan, Hassan, Al-Qarni, Hatem, Aldosari, Muath A., Alsaloum, Mohammed, Aldakheel, Ghada, Alenazi, Mohammed W., Alharbi, Naif Khalaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146373/
https://www.ncbi.nlm.nih.gov/pubmed/37112657
http://dx.doi.org/10.3390/vaccines11040744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146373/
https://www.ncbi.nlm.nih.gov/pubmed/37112657
http://dx.doi.org/10.3390/vaccines11040744

Ejemplares similares